Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
about
Usefulness of a fourth generation ELISA assay for the reliable identification of HCV infection in HIV-positive adults from Gabon (Central Africa)Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence.The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.Optimal therapy in genotype 4 chronic hepatitis C: finally cured?Diagnosis and Management of Hepatitis C Virus Infection.Mobilising a global response to hepatitis: Lessons learned from the HIV movement.A comparative study of variants of pegylated interferon alpha in treatment of chronic HCV patients.How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.Medical resource utilization and costs among Australian patients with genotype 1 chronic hepatitis C: results of a retrospective observational study.Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?Population Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based Evidence
P2860
Q35008964-7B2D4431-ED15-492E-B1BC-E06C21B1B0B2Q35058571-0B8152DF-D7F7-432B-AD2F-046D61807B0CQ37486425-8B3097DF-9632-47AB-9525-7F7B2C4A9B29Q38295814-F8EB0B9F-E27D-492D-84A4-6204B9C1A297Q38327430-07475775-9F8F-4519-B424-7F975EDCB54EQ38810895-426FC6AE-10B5-4017-84CF-EABB4D297F0FQ38985556-B449275F-F868-4CC0-A873-85A3BAC53B0DQ39315196-1A5234EB-4AAB-4CA4-9E5D-25F4F99DB8BEQ39462995-0C3C6F0E-82A5-4C4D-AD63-FC3BC57E8736Q41612169-5F35C947-8D4B-4798-98FA-5D504A2905B9Q42048758-AD8A8C93-E6A2-4E64-872A-910030FD73B3Q52597017-940E2B38-8061-4E26-82CA-043C581D6E68Q57145115-255F03BA-35EC-4ABE-91F4-DCC876672F19
P2860
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@en
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@nl
type
label
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@en
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@nl
prefLabel
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@en
Effectiveness and cost-effecti ...... resources: the case of Egypt.
@nl
P2093
P2860
P50
P356
P1476
Effectiveness and cost-effecti ...... d resources: the case of Egypt
@en
P2093
Arnaud Fontanet
Dorothée Obach
Gamal Esmat
Maria Buti
Mostafa K Mohamed
Sahar Dewedar
Sylvie Deuffic-Burban
Valérie Canva
Wagida A Anwar
Wahid Doss
P2860
P304
P356
10.1093/CID/CIU066
P407
P577
2014-02-07T00:00:00Z